Vantage Consulting Group’s BioTelemetry, Inc. BEAT Stock Holding History

Vantage Consulting Group’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-333	Closed	-$24K	–	1857
2020 Q4	$24K	Buy	+333	New	+$17.4K	﹤0.01%	808

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Vantage Consulting Group's BEAT Position: Q1 2021 in Review

Vantage Consulting Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 333 shares — an estimated $24K sold.

Vantage Consulting Group first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $24K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Vantage Consulting Group reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Vantage Consulting Group sold 333 BioTelemetry, Inc. shares in Q1 2021, an estimated $24K.
Vantage Consulting Group first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
Vantage Consulting Group's BioTelemetry, Inc. position peaked at $24K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.